The first step in the clinical development of #Moderna's #mRNA vaccine against #SARS_CoV_2 (mRNA-1273) is being conducted by #NIH under its own Investigational New Drug application.
#mRNA technology has been widely used in many #nanotechnology_patents focusing on the #coronavirus (SARS / MERS) treatment approaches.
